Oklo's Path Back to $100 Runs Through Three Tests

Oklo (NYSE: OKLO) traded at $35.86, down 0.97% on the day as of 16:25 GMT on 15 September 2026, with investors weighing its Aurora reactor, the Groves project and a Meta- and Centrus-backed Ohio strategy against a share price far below its highs and a possible route back toward $100.

Oklo Inc. (NYSE: OKLO) is one of those stocks where the chart and the operating story have been moving in opposite directions. The shares have fallen sharply from their highs, yet the company's project pipeline has kept advancing. As of the last trade at 16:25 GMT on 15 September 2026, Oklo changed hands at $35.86, down 0.97% from the prior close of $36.21, inside a day range of $35.27 to $36.47. That is a quiet session for a name that has been anything but quiet.

The question framed by Nasdaq Markets is whether three specific items — the Groves project, the Aurora reactor design and an Ohio strategy backed by Meta and Centrus — are enough to carry the stock back toward $100 a share. From Tuesday's level, that would require a gain of roughly 179%, an illustrative figure derived from the quoted price rather than any company forecast or analyst target.

What the share price is actually discounting

Oklo is a pre-revenue developer of small nuclear reactors. That single fact governs everything about how the stock behaves. There is no earnings multiple to anchor it, no order book converting into cash, no dividend to cushion a drawdown. What there is instead is a sequence of permitting, engineering and customer milestones, and a market that re-prices the whole company every time one of them moves a step closer or a step further away.

That is why the drawdown from the highs matters less as a valuation signal than it would for an industrial with real revenue. When a stock is priced almost entirely on events several years out, the discount rate does the heavy lifting. A broad risk-off day drags it more than it drags the index — and Tuesday was mildly risk-off across the board, with the S&P 500 proxy SPY at $757.70, down 0.42%, the Nasdaq 100 proxy QQQ at $705.83, down 0.47%, and the Dow tracker DIA at $520.26, down 0.81%. Against that, Oklo's 0.97% decline is a fairly ordinary beta day, not a company-specific event.

The useful discipline for anyone looking at the name is to stop arguing about whether $100 is possible and start asking what has to be true, in order, for it to become possible.

Test one: does Aurora move from design to hardware

Aurora is the reactor product itself. Everything else Oklo talks about is downstream of it. For a developer at this stage, the distinction that matters to investors is the one between a design that exists on paper and regulatory filings, and a unit that is physically being built on a site with a completion date attached.

Design maturity is what converts a speculative story into a schedule. Until Aurora clears that threshold, every customer conversation is conditional and every revenue projection is an assumption stacked on an assumption. The market has learned this the hard way across the advanced-nuclear cohort: timelines slip, costs get revised, and the equity absorbs the difference immediately.

What to watch is not press-release language but the specificity of it. Dates, sites, fuel loading, regulatory sign-offs. Vague reaffirmations of a strategy are not progress; a fixed milestone that the company then hits is.

Test two: whether Groves proves the model repeats

One reactor at one site is a demonstration. A second is the beginning of a business. The Groves project is the checkpoint that tells investors whether Oklo's approach is a factory model — standardised units, replicable siting, falling per-unit cost — or a series of bespoke engineering exercises that never get cheaper.

That distinction is the entire bull case for small modular reactors as an asset class. The economics only work if the twentieth unit costs materially less than the first. If Groves and Aurora end up looking like two custom projects rather than two instances of the same product, the growth curve that justifies a triple-digit share price flattens out.

For a pre-revenue company, repeatability is also the thing that makes financing cheaper. Lenders and project-finance investors will price a standardised, de-risked unit very differently from a one-off.

Test three: the Ohio strategy and the quality of its backers

The Ohio plan is the piece with named counterparties attached, which is why it carries disproportionate weight. Meta Platforms (META) sits on the demand side — the hyperscaler buying firm, carbon-free power for data centres — and Centrus Energy (LEU) sits on the supply side of the fuel chain. Meta last traded at $665.41, essentially flat at -0.03%, within a day range of $656.20 to $678.87. Centrus was weaker, at $141.14, down 3.49% from the prior close of $146.25, having traded as high as $147.58 and as low as $140.35 during the session.

The presence of a counterparty of Meta's size changes the character of the risk. It does not eliminate execution risk, but it addresses the offtake question that hangs over every merchant power project: who signs the contract, and are they good for it. Data-centre load growth has become the single most credible source of long-dated demand for new baseload generation, and being positioned against it is worth more than a generic decarbonisation pitch.

Centrus is the other half of the puzzle. Advanced reactors need advanced fuel, and the fuel supply chain has historically been the choke point that turns a working reactor design into a stranded asset. A domestic enrichment partner materially reduces that dependency — which is also why Centrus shares tend to trade as a sentiment proxy for the whole sector, as Tuesday's underperformance against a market down less than half a percent illustrates.

How to frame the $100 question

A move from $35.86 back to $100 is not a rerating on sentiment. On the arithmetic alone it is a near-tripling, and for a company with no revenue that has to come from the market pulling forward its confidence in a commercial timeline by years, not months. That happens when milestones are hit on schedule and contracts convert from frameworks into binding commitments.

The realistic checklist is short. Aurora reaching hardware with a credible in-service date. Groves demonstrating that the second build is faster and cheaper than the first. The Ohio arrangement producing a firm, quantified offtake with Meta and a secured fuel path through Centrus. Each one that lands removes a layer of discount; each one that slips adds it back.

Until then, Oklo remains what its price action says it is: a levered call option on the industrialisation of small nuclear, trading well below its highs, moving with the market on days when nothing about its own story has changed. Investors should size it accordingly and judge it on milestones rather than on the distance to a round number.

Frequently asked questions

What does Oklo do?

Oklo is a developer of small advanced nuclear reactors, listed on the New York Stock Exchange under the ticker OKLO. Its lead product is the Aurora reactor design, and it is also advancing a project referred to as Groves. The company is pre-revenue, meaning its valuation rests on future project milestones rather than current earnings.

Where is Oklo stock trading now?

Oklo last traded at $35.86, down 0.97% from the previous close of $36.21, as of 16:25 GMT on 15 September 2026. The intraday range was $35.27 to $36.47. The shares have fallen sharply from their earlier highs, though the company's operating milestones have continued to progress.

How much would Oklo need to rise to reach $100?

From the $35.86 price recorded on 15 September 2026, the stock would need to gain roughly 179% to reach $100 a share. That is a straightforward calculation from the quoted price and is illustrative only — it is not a price target, a forecast, or a figure issued by the company or any analyst.

What is the Meta and Centrus connection?

Meta is associated with Oklo's Ohio strategy on the demand side, reflecting data-centre operators' need for firm, carbon-free power. Centrus Energy is positioned on the nuclear fuel supply side. Meta traded at $665.41, essentially flat, while Centrus fell 3.49% to $141.14 on 15 September 2026.

Why does Centrus matter to Oklo investors?

Advanced reactors require specialised fuel, and the enrichment supply chain has historically been a bottleneck capable of stranding otherwise viable reactor designs. A domestic fuel partner reduces that dependency. Centrus shares also tend to move as a sentiment proxy for the wider advanced-nuclear sector, amplifying moves on both up and down days.

What are the main risks in owning Oklo?

Oklo has no revenue, so the share price depends entirely on future milestones: regulatory approvals, construction schedules, and converting customer frameworks into binding contracts. Timelines in advanced nuclear frequently slip, and costs get revised upward. Because it is priced on distant cash flows, the stock is also highly sensitive to interest rates and broad risk sentiment.

Sources

• Before You Buy Oklo Stock, Consider These 3 Tests — Nasdaq Markets

Photo: Gáspár Ferenc · Pexels Licence — source